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ABSTRACT 
Investigation of Experimental Variation of Bovine Sphingomyelin as a Novel Ingredient 
for Ultraviolet Protection 
Esther Natalie Chen 
Skin cancer is a prevalent disease that globally affects 2-3 million people per year 
[1]. This number is expected to grow tenfold as depletion of the ozone layer contributes 
to harsher rays reaching Earth’s surface [2]. A common way to protect against those 
ultraviolet waves is to apply sunscreen, however, recent reports call into question the 
safety of some active ingredients as they can enter through the skin into the bloodstream 
[3]. This thesis aims to investigate an alternative solution that uses bovine sphingomyelin 
(BSM) as photoprotective solution against UV irradiation. 
In order to evaluate the effectiveness of BSM against UV radiation, p21 intensity 
was measured on a monolayer of keratinocytes, as the intensity directly correlates to cell 
damage. Additionally, fluorescent sphingomyelin (FSM) was added as a treatment 
because it was created to be an analog to BSM and allowed for visualization of 
sphingomyelin within the cell.  
Differences in p21 intensities were observed with BSM and FSM showing a 
reduced p21 intensity compared to the no sphingomyelin case. FSM helped locate 
sphingomyelin within the cell and a mechanism was proposed for how it reduces cell 
damage. Lastly, high variation was seen between experimental designs. Further measures 
were needed to reduce this intra-subject standard deviation, so additional experimental 
parameters were tested such as min/max intensity values, cell count, and nucleus 
circularity to explain this variation.  
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1 INTRODUCTION 
Skin cancer is a prevalent disease that has been on the rise over the past decade. In 
2017, there were approximately 2-3 million non-melanoma skin cancer and 132,000 
melanoma skin cancer cases globally [1]. Scientists predict that with the depletion of the 
ozone level,  cases of skin cancer will continue to rapidly increase [2]. Currently, the 
FDA recommends sunscreen as a method of preventative care against skin cancer [2]. 
However, the safety of sunscreens are being called into question. In a memo published in 
January 2020, the FDA confirmed evidence that some active ingredients were absorbed 
through the skin and measured in blood levels [3]. Alternative methods for UV protection 
are needed and are the motivations for this investigation.  
Sphingomyelin is an important class of phospholipids found in most eukaryotic cells 
[4]. It is postulated that introduction of bovine sphingomyelin can provide protective 
effects from UV photodamage; however, the exact mechanism is still unknown [5]. P21 
is a cyclin-dependent kinase inhibitor that promotes cell cycle arrest in response to many 
stimuli, one being the phosphorylation of sphingomyelin to ceramide [6]. Cell cycle 
arrest can lead to DNA repair or apoptosis, but ultimately it helps the maintenance of the 
genomic integrity [7]. Typically p21 is found within cytoplasm, but will be present in the 
nucleus after cell damage [5].The presence of p21 in the nucleus helps quantify the cells 
that have taken UV damage. Using p21 as a cell damage indicator, we hypothesize that 
bovine sphingomyelin will reduce the cell damage. A series of experiments were 
designed to help understand sphingomyelin’s mechanism and to observe these 
photoprotective effects.  
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The overall goals of this thesis were to investigate the protective effects of 
sphingomyelin by observing differences in cell damage for cells exposed to 
sphingomyelin compared to those without, to visualize sphingomyelin within the cell, 
and to identify experimental parameters that could contribute to variation within results.   
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2 BACKGROUND 
2.1 Layers of the Skin 
The skin is made of two main layers: dermis and epidermis [8]. The dermis is made 
of dense, irregular connective tissue that is responsible for autonomic and sympathetic 
communication to and from the brain [9]. It also contains blood vessels, hair follicles, and 
sweat glands [9]. The epidermis functions as a waterproof barrier against the outside 
environment [10]. It contains three main types of cells that may become cancerous: 
squamous cells, basal cell, and melanocytes [11]. Keratinocytes can be found in both 
dermis and epidermis layers except at the stratum basale [11].  
2.1.1 Dermis 
The dermis is mainly responsible for supporting the epidermis; it is composed the 
papillary dermis and the reticular dermis [12]. The papillary dermis is more superficial 
and contains capillaries, elastic fibers, reticular fibers, and collagen [12]. The reticular 
dermis contains blood vessels, interlaced elastic fibers, collagen fibers in parallel layers, 
fibroblasts, mast cells, nerve endings, and lymphatics [12]. The types of cells in the 
dermis are fibroblasts, mast cell, and vascular smooth muscle cells [12].  
2.1.2 Epidermis 
The epidermis of thick skin has five layers (listed from innermost to outermost 
layer): stratum basale, stratum spinosum, stratum granulosum, stratum lucidum, and 
stratum corneum [13]. Within those layers, there are four types of cells: keratinocytes, 
melanocytes, Langerhans, and Merkel cells. Keratinocytes originate in the stratum basale 
and differentiate up to the stratum corneum; they are responsible for synthesis of keratin 
[13]. Melanocytes are found in the stratum basale and produce melanin, which is 
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responsible for hair and skin color as well as protect the living cells from ultraviolet (UV) 
radiation damage [8]. Langerhan cells originate from bone marrow and are found in the 
epidermis to detect foreign particles [13]. Lastly, Merkel cells are found in the epidermis 
of specific areas of the skin, such as nail beds or genitalia, to heighten sensitivity [13]. 
2.1.3 Keratinocytes  
Epidermal keratinocytes are responsible for separating an organism from their 
environment by producing keratin, an intermediate filament protein [14]. They start in the 
innermost stratum; these are called basal cells and they can either stay to replenish the 
population basal keratinocytes or start differentiation [15]. The differentiating cells are 
called prickle cells and are pushed outward until they reach the stratum spinosum layer 
[15]. They continue to travel outward to the stratum granulosum and become granular 
cells [15]. At this point, the cell organelles and nucleus degrade and form a highly 
keratinized squamous layer called squames which eventually flake off as dead skin cells 
[15]. 
2.2 Types of Skin Cancer 
Skin cancer is the most common type of cancer worldwide [16]. One in 5 
Americans will develop skin cancer by the age of 70 [16]. Skin cancer is classified into 
nonmelanoma skin cancer and melanoma. The most common types of the nonmelanoma 
skin cancer are basal cell carcinoma and squamous cell carcinoma [17]. 
2.2.1 Nonmelanoma Skin Cancer 
The main difference between nonmelanoma and melanoma cancer is with the 
location or type of cells that are malignant [18]. Melanoma begins in the innermost layer 
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below the stratum basale of the epidermis while nonmelanoma grows in the middle and 
upper layer of the epidermis such as the stratum granulosum [18]. 
Basal cell carcinoma (BCC) is the most common form of nonmelanoma skin 
cancer, mainly caused by acute sun exposure [16]. BCC forms in the basal cells found in 
the stratum basale of the epidermis [18]. There is an increased risk for light-
complexioned people who have painful sunburns with no tanning during exposure to 
sunlight [19]. There are five main types of BCC: nodulo-ulcerative, pigmented, cystic, 
superficial, and sclerosing; they are categorized by appearance and location [19].  
Squamous cell carcinoma (SCC) is due to the malignant proliferation of 
epidermal keratinocytes, mainly due to chronic long term solar exposure [19]. SCC forms 
in squamous cells found in the upper layer of the epidermis [18]. There is higher 
incidence for organ transplant patients to develop SCC due to increased risk factors such 
as immunosuppressive therapy, genetic factors, and skin cancer transmission before 
transplantations [20]. 
BCC and SCC both grow in a continuous, cellular structure that appear like 
narrow cellular strands [18]. They are less likely to spread to other parts of the body and 
can usually be cured if identified and treated early [18]. Typical treatments involve 
encompassing the entire tumor and eradicating the cancer with the least inconvenience to 
the patient [21]. Some common treatments include excision, Mohs surgery, electric 
cauterization, cryotherapy, and laser treatment [22]. 
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2.2.2 Melanoma  
Melanoma is when melanocytes start to grow uncontrollably and can metastasize to 
other parts of the body [23]. Compared to BCC and SCC, melanoma is harder to treat and 
is responsible for three out of every four deaths caused by skin cancer [24]. Phenotypes 
with higher risk of melanoma are those with fair skin, fair or red hair, tendency to freckle, 
and tendency to burn rather than tan [24]. Similar BCC, acute sun exposure is more 
highly associated with melanoma risk rather than chronic exposure [24]. Diagnosis is 
dependent on location and its growth pattern; there are five main types: Lentigo maligna 
melanoma (LMM), superficial spreading melanoma (SSM), nodular melanoma (NM), 
acral lentiginous melanoma (ALM), and mucosal melanoma (MCM) [24].  
2.3 Sunscreen 
One of the most important methods for skin cancer protection is the application of 
sunscreen. Sunscreen uses inorganic particles to reflect and scatter UV waves and organic 
particles absorb and release UV rays in the form of heat [25]. Currently, FDA 
recommend consumers use broad-spectrum sunscreens with SPF 15 or greater [2]. 
However, there are concerns regarding sunscreen ingredients that can be absorbed 
through the skin to the bloodstream. New FDA regulations that recommend additional 
safety testing for the following commonly used ingredients in the U.S.: ensulizole, 
octisalate, homosalate, octocrylene, octinoxate, oxybenzone, and avobenzone [26]. These 
active ingredients have the potential to mimic hormones or cause skin allergies, and 
testing is needed to confirm they do not cause endocrine disruption, cancer, or other 
health harms [27].  
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2.4 Ultraviolet Light 
Ultraviolet light is wave within the region in the electromagnetic spectrum with a 
wavelength between 400 to 10 nanometers [28]. In this spectrum, UV radiation has 
enough energy to cause ionization that breaks electrons from atoms [29]. The Sun is the 
source of ultraviolet radiation and can be categorized into UV-A, UV-B, and UV-C [30]. 
UV-C rays, 100-290nm, are the most harmful but do not pass Earth’s ozone layer. About 
95% of the UV-B rays, 290-320nm, are absorbed by the ozone in the stratosphere, and 
UV-A, 320-400nm, has the longest wavelength that reaches Earth’s surface in greatest 
quantity [31]. UV-A has enough energy to penetrate the epidermis, dermis, and 
hypodermis, while UV-B can penetrate only through the epidermis and slightly into 
dermis [31]. Therefore, UV-A and UV-B reaches humans and increases sunburn and the 
risk of DNA and cellular damage; this increases the risk of skin cancer [32]. These 
properties of UV light allow for other applications in sterilization/disinfection, 
fluorescence/lighting, and curing [33]. 
2.5 Cell Anatomy 
The human body is made up of eukaryotic cells that contain a cell membrane, 
cytoplasm, and organelles. The cell membrane acts as a barrier that regulates 
incoming/outgoing materials that is made up of two phospholipids with their hydrophilic 
heads facing outward and hydrophobic tails facing each other called a phospholipid 
bilayer [9]. The cytoplasm is a watery interior that houses ions, proteins, and organelles 
that are responsible for hemostasis [9]. 
Organelles perform specialized tasks and work symbiotically to allow for 
differentiation among cells. Some of the most important organelles are highlighted in 
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Figure 1. Protein rich organelles such as intermediate filaments, microtubules, and 
microfilaments provide structural integrity and allow movement [9]. The ribosomes 
attached to endoplasmic reticulum and free-floating ribosomes are responsible for protein 
production [9]. The golgi apparatus processes proteins and packages them in vesicles 
called lysosomes [9]. Mitochondria generate energy for the cell [9]. Lastly, the nucleus 
contains the cell’s DNA which carry the instruction for all processes [9]. The nucleus is 
surrounded by a nuclear membrane that limits entering and exiting similar to the cell 
membrane [9].  
 
Figure 1: Cell Anatomy. 
2.6 DNA Damage  
UV light can directly and indirectly cause DNA damage. A photon of UV light can 
directly activate the DNA by fusing two pyrimidine base pairs together and causing 
difficulty in replication [34]. It can also damage the DNA indirectly by causing melanin 
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Golgi Apparatus 
Intermediate Filaments 
Microfilaments 
Microtubules 
Lysosome 
Rough Endoplamic  
Reticulum 
Nucleus 
Smooth Endoplamic  
Reticulum 
9 
 
to react an adjacent oxygen atom and forming a reactive species [34]. Activated oxygen 
reactive species can interact with the DNA to replace purine guanine to pyrimidine 
thymine and cause incorrect transcription [34]. Furthermore, activated oxygen can also 
interact with hydrogen and form two hydroxyl radicals that attach to the DNA’s 
backbone (deoxyribose) and break the strand or release a base pair [34]. Defense 
mechanisms such as nucleotide excision repair, base excision repair, and increased 
melanin production all try to combat UV damage [34]. 
2.7 P21 
Cyclin kinase inhibitors (CKIs) are proteins that bind to cyclin and prevent the 
phosphorylation activities of cyclin-dependent kinases (CDKs) [35]. The main function 
of CDKs is to promote transcription and mitosis; CKIs work to prevent these processes 
[36]. CKIs are important tools in controlling proliferation of cells that have experienced 
damage or mutations [36]. P21 is one type of cyclin-dependent kinase inhibitor that 
affects the following mechanisms: cell cycle, DNA replication/repair, and apoptosis [37].  
During the cell cycle, CDKs are activated by pairing with specific cyclins 
corresponding to different checkpoints for cell replication [38]. During one of these 
phases, p21 inhibits progression of the cell cycle by binding G1/S-phase and S-phase 
CDKs and blocking cell from entering S phase [37]. Proliferating cell nuclear antigens 
(PCNAs) are responsible for DNA replication and/or repair [39]. P21 inhibits DNA 
replication by binding to PCNAs rendering them unable to activate DNA polymerase 
[39]. Lastly, p21 has been observed to be cleaved by caspase 3, a protease enzyme 
responsible for DNA fragmentation, which causes abnormal cell apoptosis [40]. These 
mechanisms promote cell cycle inhibition, but surprisingly, protects the cell from 
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immediate apoptosis because an active cell cycle is needed to trigger apoptosis [7]. 
Therefore, p21 detection was used as the metric for measure cell damage due to UV 
irradiation.  
2.8 Sphingomyelin 
Sphingomyelin (SM) is prevalent in many mammalian cells and tissues and some 
major functions include creating lateral structures (e.g. Lipid rafts) and interacting with 
membrane-spanning proteins and cell signaling events [4]. SM is composed of long-chain 
bases, fatty acids, and a glycerol-based backbone [4]. 
2.8.1 Lipid Rafts  
Within the fluid bilayer, SM and cholesterol form lipid rafts that are tightly 
packed due to the hydrophobic nature of their saturated fatty acid side chains [41]. 
Cytoplasmic proteins attach to these rafts by covalently bonding to the saturated fatty 
acids and cell surface proteins attach via glycosylphosphatidylinositol [41]. 
Glycosylphosphatidylinositol is a lipid anchor that covalently attaches to the carboxyl 
terminus of cell surface proteins [42]. Lipid rafts are especially important in trafficking 
proteins from the Golgi complex to the cell surface and vice versa because they ensure 
specificity and fidelity [43].  
2.8.2 Signaling Pathways  
Sphingomyelin is involved in many signaling pathways, one being its role in 
apoptosis. The sphingolipid ceramide pathway is hypothesized to be the key regulator of 
programmed cell death. This pathway involves sphingomyelin using the enzyme 
sphingomyelin synthase to form ceramide and phosphorylcholine [44]. Ceramide is a 
neutral, lipid molecule composed of long-chain sphingoid base, sphingosine, and a 
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variety of acyl groups [45]. Ceramide then works to activate nuclear factor kappa light 
chain enhancer of activated B cells (NF-κB) [46]. The primary function of NF-κB is the 
transcription of genes that activate cell apoptosis [47].  
2.8.3 Bovine Sphingomyelin 
Bovine sphingomyelin (BSM) was selected because it is found in common foods, 
such as dairy products, eggs, and soybeans, and it has a consistent molecular structure 
[48]. Its uniformity in molecular structure may be due to the cows’ consistent, 
controllable diet [48]. Figure 2 shows the chemical structure of BSM; its composed of 
sphingosine, fatty acid residue, and phosphocholine group [49]. It has a molecular weight 
of approximately 785 g/mol that slightly fluctuates based on the fatty acid distribution, 
and it was obtained in powder form [49].   
 
Figure 2: Bovine Sphingomyelin. Representative structure of one of many possible 
structures. [49] 
2.8.4 Fluorescent Sphingomyelin 
Currently, BSM tracking efforts using confocal microscopy do not work because 
the SM is not fluorescent. Fluorescent sphingomyelin (FSM) was developed to track 
intracellular mechanisms. FSM differs from BSM by the introduction of a fluorescent tag 
marked by a red rectangle in Figure 3 [50]. Avanti Polar Lipids Inc. manufactures a 
specific FSM labeled C6-NBD Sphingomyelin that has a molecular weight of 741 g/mol 
and chemical formula of C35H61N6O9P [51]. Similar to BSM, it was obtained in powder 
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form. However, modification was needed to suspend the FSM in light limiting conditions 
due to light sensitive nature of FSM.  
 
Figure 3: Fluorescent Sphingomyelin (FSM). The red rectangle marks chemical 
structure of the fluorescent tag. [51] 
2.8.5 Dietary Sphingolipids 
Recent research shows that certain dietary changes can reduce the prevalence of 
nonmelanoma skin cancer [52]. Sphingolipids are found in all types of foods, the most 
common being dairy products, eggs, and soybeans [53]. Sphingolipids in nutrition could 
be an avenue of skin cancer prevention [53]. Dietary sphingolipids have been studied in 
mice and there is a correlation between the amount of sphingomyelin fed versus amount 
found in the colon [54]. Consumption of sphingomyelin affects the behavior of colonic 
cells and inhibits the formation of colon cancer [55]. Furthermore, low doses of 
sphingolipids were effective in inhibiting carcinoma development [56]. 
Understanding the metabolism of sphingomyelin within skin cells is the first step in 
developing supplements or promoting certain diets that can help prevent skin cancer. 
2.9 Previous Experimentation 
Previous experimentation was done by California Polytechnic Bioimaging Lab to 
establish protocols for BSM incubation, UV irradiation, and immunostaining, found in 
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Appendix A. This protocol was used for preliminary testing and to confirm results 
previously found by Campbell [57]. Experimentation performed by Campbell suggested 
BSM photoprotection exists for a monolayer of keratinocytes [57]. 
Additionally, experimentation by Kandell determined the FSM protocol for use 
with keratinocytes as well as possible reduced BSM and FSM incubation time points [5]. 
These time points were tested using a new secondary AF 594 to determine at which time 
FSM and BSM shared the same photoprotective effects, Section 4.4.  
Lastly, efforts made by Fraser outlined a systematic approach for image analysis 
[58]. With the use of macros, ImageJ produced quantitative results that eliminated 
possible bias if images were processed manually. Macros for data analysis are found in 
Appendix B.  
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3 METHODS 
3.1 Keratinocyte Cell Culture 
Human Epidermal Keratinocytes from Neonatal Foreskin (HEKn PCS-200-010, 
ATCC Manassas, VA) were cultured in physiological conditions (37°C, 5% CO2) with 
aseptic techniques with media being replaced every two days. Media was prepared under 
manufacturer guidelines of combining a Keratinocytes Growth Kit (PCS-200-040, 
ATCC, Manassas, VA) with Dermal Cell Basal Media (PCS-200-030, ATCC, Manassas, 
VA) and sterile filtering the solution with a 0.22um filter. For experiments, cells were 
expanded in T-75 Corning Tissue Culture Flasks (BD353136, VWR, Visalia, CA) and 
passed into 8-well Nunc Lab-Tek Chambered Coverglasses from Thermo Scientific 
(43300-774, VWR, Visalia, CA). Passage number of keratinocytes for all experiments 
ranged between 4-5. Morphology was assessed and confluency was at least 70% before 
any experimentation. 
3.2 Sphingomyelin Treatment 
3.2.1 Bovine Sphingomyelin Solution 
A 0.1% bovine sphingomyelin (BSM) solution was made by combining Bovine 
Milk Sphingomyelin (860063P-25mg, Avanti Polar Lipids, Alabaster, AL) and 
keratinocyte media solution. To determine the amount of keratinocyte media solution 
needed for the mixture, the number of wells was multiplied by 0.4 mL (0.4 mL*(# of 
Wells)). To determine the amount of BSM needed for a 1% BSM solution, that volume 
was then converted into grams and multiplied by 0.001 (0.4 mL*(# of Well)*(1 gram / 1 
mL)*0.001 grams). These components were vortexed until homogeneous and the solution 
was sterilized using a 22 mL filter.  
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Prior to use, BSM solution was warmed in a 37°C water bath. When the 
keratinocytes reached a confluency of 70% or greater, the keratinocyte media solution 
was aspirated and 200 µL of BSM solution was dispensed to each well. Experimentation 
was done to analyze optimal incubation period in Section 4.4. BSM was incubated for 2 
hours unless specified. 
3.2.2 Fluorescent Sphingomyelin Solution 
Fluorescent SM (FSM) or C6-NBD Sphingomyelin (810218P-1mg, Avanti Polar 
Lipids, Alabaster, AL) was dissolved in 1.35 mL of ethanol (200 proof 100%) to obtain a 
1 mM stock solution. It was stored in the freezer (-20 °C) in a glass container and 
protected from light. In order to make 10mL of fluorescent sphingomyelin (FSM), 10mL 
of keratinocyte media solution, 50 µL of ethanol-FSM stock, and 3.5 mg of Bovine 
Serum Albumin (BSA) were combined. These components were vortexed until 
homogeneous and a 22 mL filter was used to sterilize the solution. The solution was then 
refrigerated and covered to avoid light exposure.  
Prior to use, the FSM solution was warmed in a 37°C water bath. When the 
keratinocytes reached a confluency of 70% or greater, keratinocyte media solution was 
aspirated and 200 µL of FSM was dispensed to each well. Experimentation was done to 
analyze optimal incubation period in Section 4.4. FSM was incubated for 2 hours unless 
specified. 
3.3 UV Treatment 
UV irradiation treatment exposed strong UV radiation to skin cells that would 
cause cell damage or cell death. In order to maintain aseptic conditions, all equipment 
was sprayed with 70% Isopropyl Alcohol (IPA) before placement in the culture hood. To 
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calculate UV exposure time, a UV lamp (95-0251-01, UVP, LLC, Upland, CA) was 
placed on top of a black containment box and a UV sensor (S120UV, ThorLabs, Newton, 
NJ) was placed on the blue slider meant to be the treatment surface, shown in Figure 4.  
 
Figure 4. UV irradiation. Components included UV lamp, black containment box, blue 
slider as treatment surface, and UV sensor connected to power meter.  
Initially, calibration was needed to determine the strength of the UV lamp on the 
treatment surface. After approximately 5 minutes of the UV lamp being turned on, the 
UV sensor was placed on the treatment surface and the power meter (PM100, ThorLabs, 
Newton, NJ), connected to the sensor, outputted the average power intensity in µW. The 
power was divided by the sensor area of 0.7088cm2 to get the average measured 
irradiance of the UV lamp. Optimal UV irradiation was determined from previous lab 
experimentation to be 40 mJ/cm2, Section 2.9. In order to administer this amount, 
exposure time was determined using Equation 1. 
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𝐸𝑥𝑝𝑜𝑠𝑢𝑟𝑒 𝑇𝑖𝑚𝑒 (𝑠𝑒𝑐𝑜𝑛𝑑𝑠) =  
ை௣௧௜௠௔௟ ௎௏ ூ௥௥௔ௗ௜௔௧௜௢௡ ቀ ೘಻
೎೘మ
ቁ
ቀ భ೘ೈభబబబഋೈቁ∗ெ௘௔௦௨௥௘ௗ ூ௥௥௔ௗ௜௔௡௖௘ ቀ
ഋೈ
೎೘మ
ቁ
 (Equation 1)   
Exposure time was typically 90 seconds. After exposure time was determined, the 
plate’s media was aspirated and new keratinocyte media solution was dispensed. The 
plate’s top covering was removed and the plate was placed on the treatment surface for 
the calculated exposure time. Treatment was applied to all wells in a plate and no 
modifications of the plates were done to try to differ UV treatments within each plate. 
After UV irradiation, plates were stored in an incubator for an additional 24 hours before 
being fixed.  
3.4 Fixed Cells for Immunostaining 
Fixation preserves biologics from decay due to autolysis or putrefaction. It stops 
ongoing cellular mechanisms and increases their stability [59]. The three steps for cell 
fixation are fixation, permeabilization, and blocking.   
Figure 5 is a visual representation of the steps of cell fixation. In Figure 5A, 
fixation stops cellular mechanisms and turns cells from dynamic to static. In Figure 5B, 
permeabilization introduces gaps in the lipid membrane of the outer wall and nucleus. In 
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Figure 5C, blocking prevents binding of non-target molecules such as the organelles in 
the cell.  
 
Figure 5: Steps of Cell Fixation. A. Fixation, cross-links plasters cell into a static state 
B. Permeabilization, creates gaps within the cell membrane and nucleus C. Blocking, 
reduces interaction with non-target molecules. 
3.4.1 Fixation 
Cells were fixed prior to immunostaining to allow antibodies to access 
intracellular structures. Fixation using paraformaldehyde caused covalent cross-links 
between molecules and plastered them together while they would otherwise fall apart and 
diffuse away [60].  
Paraformaldehyde 16% (EM Grade 15710, Electron Microscopy Sciences) was 
combined with 1% Phosphate Buffered Solution (PBS) to create paraformaldehyde 3.7% 
(PFA). Twenty-four hours after UV irradiation, the media was removed from wells and 
one wash was performed with PBS. PBS was then removed, and wells were fixed with 
200 µL of PFA. Plates were incubated for 15 minutes while minimizing light exposure. 
After allotted time, wells were washed three time with PBS. 
A B C 
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3.4.2 Permeabilization 
Permeabilization breaks and removes cellular membrane lipids to allow large 
molecules such as antibodies to enter a cell and its nucleus. Triton X-100 was combined 
with 1% PBS to create 0.1 %Triton X-100 solution. After fixation, plates were incubated 
for 20 minutes with 200 µL of Triton X-100 and three more washes of PBS were gently 
applied. 
3.4.3 Blocking 
Blocking is important to reduce the amount of interaction between the 
immunostaining antibodies and non-target molecules called non-specific binding. This 
reduced nonspecific “background” staining and increased signal to noise ratio [61]. 
Normal Goat Serum 10% (500622, Life Technologies) was combined with 1% PBS to 
create 1% blocking solution. After permeabilization, plates were incubated approximately 
for 12 hours at 4°C with 200 µL of blocking solution. Three more washes of PBS were 
done prior to immunostaining.  
Fixation, permeabilization, and blocking steps for experiments were outlined 
above. Table 1 summarizes concentrations, incubation times, and materials for each of 
these steps.  
Table 1: Cell Fixation. 
Procedure Concentration Incubation 
Time 
Materials Manufacturer 
Fixation 3.7% 15 minutes Paraformaldehyde 
PBS 
Electron 
Microscopy 
Sciences 
 
Permeabilization 0.1% 20 minutes Triton X-100 
PBS 
Invitrogen 
HFH10 
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Blocking 1% ~12 hours Normal Goat 
Serum 
PBS 
Life 
Technologies 
 
3.5 Immunostaining 
Dual labeling is a staining method that uses two antibodies to target a specific 
antigen and to allow for immunofluorescent tagging. P21 is the protein of interest and the 
indirect immunostaining protocol was previously optimized by the lab, Section 2.9. 
Figure 6 is a visual representation of immunostaining of a cell. In Figure 6A, indirect 
immunostaining targeted p21 to appear green under a certain emission spectrum. Further 
staining of the cell’s nuclei under a different emission spectrum was done to quantify cell 
count in  Figure 6B.  
 
 
Figure 6: Immunostaining of Cell. A. Indirect immunostaining allows fluorescence of 
p21. B. Hoechst allows fluorescence of cell’s nucleus. 
A closer observation of indirect immunostaining is found in Figure 7. Figure 7A 
represents the target molecule, in this case, it is p21. In Figure 7B, the primary antibody 
has specific receptors that attaches to antigen. Lastly in Figure 7C, secondary antibodies 
A B 
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have specific receptors that attach to that primary antibody. These secondary antibodies 
have fluorescent tags that emit light under a specific range frequency.  
 
Figure 7: Indirect immunostaining. A. Target molecule B. Primary binds to that 
specific antigen C. Secondary with fluorescent tag binds to primary. The signal/intensity 
is amplified because more than one secondary can bind a primary. 
3.5.1 Primary 
The primary antibody binds to the specific p21 antigen. Following blocking, 
plates were incubated with a primary antibody. Anti-p21 antibody rabbit (Abcam 
ab18209) was combined with 1% PBS to create 1:400 p21 antibody. Plates were 
incubated for 9 hours at 4°C with 200 µL of p21 antibody. The primary was then washed 
off gently 3 times with PBS. 
3.5.2 Secondary 
The secondary antibody binds to the heavy chains of primary antibody that do not 
interfere with primary antibody’s binding to antigen [62]. Two secondary antibodies, 
carrying different-colored fluorophores, were used to visualize p21 concentration within 
the cell. Two secondaries were needed because FSM shared the same emission spectrum 
as the initial secondary. Figure 8A/8B illustrates treatments of no sphingomyelin and 
A B C 
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BSM using the first primary, AF 488 goat, anti-rabbit IgG (ThermoFisher Scientific A-
11008). In Figure 8C, the clarity of p21 presence was lost because FSM shares the same 
emission spectrum and would add to its intensity. In order to mitigate this, a new 
secondary, AF 594 goat, anti-rabbit IgG (ThermoFisher Scientific A11037), with a 
different emission spectrum was introduced to separately quantify FSM and p21, Figure 
8D. 
 
 
Figure 8: Fluorescence Emission for Different Secondaries. A. p21 stained with 
Secondary AF 488. B. p21 stained with Secondary AF 488 with the introduction of BSM. 
A B 
C D 
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C. p21 stained with Secondary AF 488 with the addition of FSM. They fluoresce the 
same color because they share the same emission spectrum. D. p21 stained with 
Secondary AF 594. FSM fluoresces green while p21 fluoresces red. 
AF 488 goat, anti-rabbit IgG was combined with 1% PBS to create 1:400 AF 488 
secondary. Experimentation with AF 594 goat, anti-rabbit IgG) and 1% PBS was 
summarized in Section 4.3 in order to optimize fluorescence using a 1:200 AF 594 
secondary.  Following primary, plates were incubated for 1 hour with 200 µL of either 
AF 488 or AF 594 secondary. The secondary was then washed off gently 3 times with 
PBS. 
3.5.3 Nuclear Staining 
Lastly, nuclear staining was introduced to help focus cells during confocal 
microscopy, check their viability qualitatively, and obtain a cell count to help normalize 
intensities between UV and non-UV cases. Hoechst 34580 (Life Technologies H21486) 
binds to all nucleic acids and has a blue fluorescent excitation and emission. Hoechst 
34580 was combined with 1% PBS to create 0.015% Hoechst stain after reduction of 
0.03% Hoechst was deemed equivalent, from experimentation found in Section 4.3. 
Following secondary, plates were incubated for 15 minutes with 200 µL of Hoechst stain. 
The Hoechst stain was then washed off gently 3 times with PBS. This concluded the 
immunostaining procedure. PBS was added to each well, plates were wrapped in foil to 
limit light exposure, and confocal imaging was done soon after immunostaining.  
Primary, secondary, and nuclear staining steps for experiments were outlined 
above. Table 2 summarizes concentrations, incubation times, and materials for each of 
these steps.  
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Table 2: Immunostaining. 
Procedure Concentration Incubation 
Time 
Materials Manufacturer 
Primary 1:400 9 hours Anti-p21 
antibody 
rabbit 
PBS 
Abcam 
Secondary 1:200 (refer to 
Section 4.3) 
1:400 
1 hour AF 594 goat, 
anti-rabbit IgG 
AF 488 goat, 
anti-rabbit IgG 
PBS 
ThermoFisher 
Scientific 
Nuclear 
Staining 
0.015% (refer to  
Section 4.3) 
15 minutes Hoechst 
34580 
Life 
Technologies 
 
3.6 Confocal Imaging 
Olympus FluoView FV1000 is a confocal laser scanning biological microscope that 
allows for fluorescent imaging. The FluoView desktop software allows capture of 
multiple laser channels when captured sequentially. The following laser channels were 
used: DAPI for Hoechst, 488 laser for Alexa Fluor 488, and 594 laser for Alexa Fluor 
594. The 20X objective was used to ensure equal cell distribution, 40X oil objective for 
p21 positive analysis, and 100x oil objective for FSM localization analysis. Images were 
saved in Olympus Image Binary format (.oib) with a size of 512x512, 16-bit, and 512K. 
Three images in the center of each well were taken to avoid unequal distribution of 
UV that came when cells were closer to the edge of the well. High voltage (HV) and laser 
power were optimized for treatment for every experiment. HV is attenuation of voltages 
to increase signal, but if too high, it can also create visible noise [63]. Laser power refers 
to the percentage reduction of light using filters such as neutral density filters [63]. The 
settings for each experiment are summarized in Table 3.  
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Table 3: Optimized Laser Settings per Stain. 
Experiment Stain High Voltage (HV) Laser Power 
1: Section 4.1 DAPI 700 1.5% 
AF 488 700 19% 
2: Section 4.2 DAPI 700 1.5% 
AF 488 700 5% (FSM 
Treatment) 
19% (BSM 
Treatment) 
AF 594 900 15% 
3: Section 4.3 DAPI 700 1.5% 
AF 594 700 18% 
4: Section 4.4 DAPI 700 1.5% 
AF 488 700 3% 
AF 594 700 18% 
5: Section 4.5 DAPI 700 1.5% 
AF 488 700 6% (FSM 
Treatment) 
15% (BSM 
Treatment) 
AF 594 700 18%  
6: Section 4.6 DAPI 700 2% 
AF 488 700 10% 
 
Figure 9 captures the confocal microscope’s user interface and outlines location 
of settings for the different channels. The dashed, red rectangle highlights where the user 
changes the HV and the solid, red rectangle is where the user changes laser power. 
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Figure 9: Image of FluoView FV1000 User Interface. The dashed, red rectangle is 
where user adjusts High Voltage. The solid, red rectangle is where user adjusts Laser 
percentage. 
3.7 Image Analysis 
ImageJ is an open-source, Java-based program that provides quick, automated 
image processing ideal for cell analysis. After confocal imaging, the images in .oib 
format were opened in ImageJ, color channels were separated, and macros ran a series of 
functions to quantitatively measure images. A macro is a file that contains a series of 
steps that execute automatically once specific inputs are given [64]. Appendix B shows 
the macros used in experiments. 
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A variety of quantitative measurements were performed on the images, summarized 
in Table 4. The types of measurements were related to either the nucleus or the image 
intensity. Nuclei viability directly correlates with cell health; measurements such as area, 
shape descriptors, skewness, fit ellipse, and perimeter were taken for each nucleus to 
understand how nuclei behave pre and post UV irradiation. Image intensity tried to 
quantify how much p21 was present in the overall image to indicate how much cell 
damage occurred. Measurements such as mean gray value, min/max value, integrated 
density, mode, and median outputted quantitative values for the p21 channel. 
Significance was tested for each measurement to determine the important parameters that 
were influenced by treatments was performed in Section 4.1.  
Table 4: Quantitative Measurements Available on ImageJ 
Measurement Description 
Area Measures area of selection in square pixels 
Shape Descriptors:  
Circ. (circularity) 4π*area/perimeter2  
Output ranges from 0 (elongated shape) to 1 (perfect circle) 
AR (aspect ratio) major_axis/minor_axis 
Ratio of cell’s size in specified dimensions 
Round (roundness) 4*area/(π*major_axis2) 
Inverse of the aspect ratio 
Solidity area/convex area 
Skewness Coefficient of skewness (symmetry) in x and y 
= 0 symmetric  
< 0 asymmetric to the left (tail extends left of center of mass)  
> 0 asymmetric to the right (tail extends right of center of mass) 
Centroid Average of all x and y coordinates to get center point of selection 
Perimeter Length of outside boundary of selection 
Fit Ellipse Finds best fitting ellipse of selection 
Mean Gray Value Sum of the gray values of all the pixels in the selection divided by the 
number of pixels 
Standard Deviation Standard deviation of the gray values used to generate the mean gray 
value 
Min and Max Gray 
Value 
Minimum and maximum gray values within the selection 
Integrated Density:  
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IntDen Product of Area and Mean Gray Value 
RawIntDen Sum of the values of the pixels in the image 
Modal Gray Value Most frequently occurring gray value in the image 
Median The median value of the pixels in the image 
[65] 
3.7.1 Cell Count 
The main reason for staining for nuclei was to obtain an accurate cell count. 
During UV irradiation, cells were killed and this reduced the number of cells per well. 
Because intensity measurement was taken per image, cell count was used to help 
normalize results between pre and post UV. Appendix B outlines the macro used for this 
analysis. 
Cell nuclei were used for cell count measurement because they tended to maintain 
a more circular structure than cells’ outer lipid bilayer. The program was able to isolate 
for circular structures and count how many were present per image. Initial optimization 
was required to establish a minimum radius to be considered a nucleus. Figure 10A 
shows how images from the DAPI channel were made binary and Figure 10B shows the 
cell count without a minimum radius. Small effects in noise were considered nuclei and 
greatly overestimated the number of cells present. Figure 10C shows the implementation 
of a minimum radius of 90 pixels in order to reduce the effect of noise and increase the 
level of accuracy.  
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Figure 10: Cell Count Image Processing. A. Binary conversion of DAPI channel B. 
Cell count without minimum pixel radius C. Cell count with minimum pixel radius of 90. 
3.7.2 Image Intensity 
To study the amount of cell damage due to UV irradiation, p21 intensity was 
measured. Presence of p21 is directly proportional to an increase in cell damage and 
differences in intensity support the effectiveness of sphingomyelin against UV 
irradiation. P21 intensities were taken per image and mean, min, max, median, and mode 
were initially analyzed for significant differences, Section 4.1. The use of two 
secondaries were used based on the treatment given (i.e. BSM v. FSM) explained in 
Figure 8. Therefore, images were separated based on their secondary treatment and 
comparisons were limited to wells sharing the same secondary type. Appendix B outlines 
the macro used for this analysis. 
3.7.3 Nested Values 
A nested design or hierarchical design is when a factor is a subset of another. In a 
nested design, each observation has a unique identity because it has a specific factor not 
replicated across each treatment [66]. Current experimentation methods yield a 2-level 
nested design where each observation is unique because its location among the 8 wells 
and its overall plate is not consistent per treatment, shown in Figure 11.  
B C A 
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Figure 11: Nested Factors. Each Image has a factor of Well, and each Well has a factor 
of Plate. 
A linear model can be used to explain this nest design where the response variable 
is affected by the treatment as well as the variability from each factor, Equation 2.  
𝑦௔௕௖ = 𝜇 + 𝛼௔ + 𝛽௕(௔) + 𝜀௔௕௖   (Equation 2) [67] 
where 
𝑦௔௕௖  response variable 
𝜇  overall mean 
𝛼௔  effect of factor Plate 
𝛽௕(௔)  effect of factor Well within each level of Plate 
𝜀௔௕௖  unexplained variation (error term) – variation within each Image 
  
There is a significant effect of p21 intensity results due to the Well and due to the 
Plate. In order to negate these effects, values were averaged per plate and sample size 
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was determined by number of plates. This greatly reduced the number of samples, 
however, it allowed analysis of effects of treatments rather than effects due to nested 
factors.  
3.7.4 Gaussian Blur 
Gaussian blur is a way to apply a low-pass blurring filter to an image in order to 
reduce noise and detail. The Gaussian function creates new image by taking a weighted 
average with the colors near the pixel of interest having more weight than those farther 
away. This removes or smooths rapid changes in pixel intensity and reduces the number 
of “outlier” pixels that can cause noise [68].  
A Gaussian Blur plugin was installed to ImageJ for image processing [69]. The 
gaussian blur was applied to images in order to observe FSM localization, Section 4.5. In 
Figure 12A, a line of interest was made across a cell to determine its intensity and Figure 
12B shows its profile plot without filtering. A clearer intensity profile was observed after 
applying Gaussian Blur, Figure 12C. This was because the overall intensity was captured 
without the noise of the pixels. It was concluded gaussian blur was an appropriate 
filtering method prior to analyzing FSM location within a cell.  
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Figure 12: Gaussian Blur. A. FSM Channel with the line of interest for profile plot 
across the diameter of cell. B. Profile plot without filtering. C. Profile plot with Gaussian 
Blur filter. 
  
A 
B C 
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4 SUMMARY OF EXPERIMENTS 
Table 5: Summary of Experiments. 
Experiment Goal Thesis Section 
1. Replication of Previous 
Experimentation 
1: Replicate procedure and 
compare results. 
2: Identify new parameters that 
introduces variation between 
treatments. 
 
 Section 4.1 
2. FSM Treatment 1: Replicate FSM procedure 
2: Introduce new Secondary AF 
594 
 
Section 4.2 
3. Optimizing New Secondary 
Concentration 
1: Optimize for new Secondary 
AF 594 
2: Evaluate reduction of 
Hoechst concentration 
 
Section 4.3 
4. Optimizing Incubation Time 1: Optimize FSM incubation 
with new Secondary AF 594 
concentration 
 
Section 4.4 
5. FSM Localization 1: Compare FSM with BSM 
2: Observe the distribution of 
FSM within keratinocytes 
 
Section 4.5 
6. Experiment replication with 
updated protocol 
1: Replicate previous 
experimentation results using 
new substrates, materials, and 
slightly modified procedure 
2: Understand variation 
between experiments 
 
Section 4.6 
7. Compiled data analysis 1: Understand inter and intra 
subject variation 
2: Evaluate treatment effects on 
new parameters and its 
significance 
3: Estimate number of trials 
needed for statistical 
significance 
 
Section 4.7 
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4.1 Replication of Previous Experimentation 
4.1.1 Objectives/Methods  
The main purpose for this experiment was to replicate results using the protocol 
created by previous lab’s experimentation. Previous lab experiments found the optimal 
procedure for UV treatment, staining, and analysis, Section 2.9. This procedure was 
documented in Appendix A and replication efforts were needed to confirm results and 
identify new parameters of interest.  
Goal 1: Replicate procedure and compare results. 
Replication of previous experiments ensures results are valid and that protocol is 
immune to external variation. Some key sources of external variation include handling 
techniques of the engineer performing experiment and specific batch of reagents used. 
This experiment documents that these sources of variation were minimized, and results 
were compared to previous experiments. 
Goal 2: Identify new parameters that introduces variation between treatments. 
Treatments, staining, and confocal imaging remained unchanged for this 
experiment, however, investigation of ImageJ image processing software showed 
additional quantitative functions that could be applied to the images summarized in 
Section 3.7. New parameters were tested for significance in the hopes that they would 
further explain the variation between treatments.  
Experimental procedure was not modified from protocol established by previous 
lab experiments, Appendix A. Lab culturist seeded 8, 8-well plates and incubated/feed 
plates until the center of each well had a confluency greater than 70%. There were 2 
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explanatory factors, SM and UV, that were crossed to produce 4 different treatments 
distributed to 2 plates each, Figure 13. The different treatments were No SM + No UV, 
BSM + No UV, No SM + UV, and BSM + UV.  
 
Figure 13: Design of Experiment 1. There was a total of 8 plates. There were 4 
treatments with 2 plates receiving each treatment.  
4.1.2 Results 
For this experiment, the lab protocol, shown in Appendix A, was replicated. 
Success of immunostaining was observed to be qualitatively appropriate. In Figure 14A, 
the DAPI channel had distinct globular outlines assumed to be cells’ nuclei. In Figure 
14B, the AF 488 channel had some high fluorescence areas corresponding to the globular 
outline in the DAPI channel. This indicates that there was p21 damage markers caused 
presumably by the UV irradiation.  
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Figure 14: Experiment 1 Confocal Imaging. A. DAPI Channel displaying cell nuclei. 
B. AF 488 channel displaying p21 indirect immunostaining.  
Images were then quantitatively assessed using ImageJ. The cell count macro was 
used on the DAPI channel and the intensity macro applied on the AF 488 channel, found 
in Appendix B. Additionally, new parameters were also evaluated for the shape of cell 
nuclei and for intensity measurements such as min and max, summarized in Table 4. 
Because each well was tied to their specific plate, nested techniques were used the find 
the average of the values per plate, Section 3.7.3. Statistical analysis lacked power 
because sample size for each treatment was 2, but observing trends was sufficient for this 
experiment.  
Cell count was first analyzed to understand how many were killed during UV 
treatment. UV irradiation was effective in producing cell death shown by a significant 
decrease in cell count between UV and non-UV treated plates, Figure 15. Plates treated 
with BSM had an average of 45 cells per image before UV irradiation and an average of 
29 cells per image post. Plates treated with no sphingomyelin had an average of 67 cells 
A B 
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per image before UV irradiation and an average of 28 cells per image post. Variation in 
cell count between No SM + No UV and BSM + No UV may be due to a combination of 
plate variation and an enlargement of cells due to BSM addition. 
 
Figure 15: Experiment 1 Cell Count (n=8). 
In order to analyze the difference of p21 concentrations between treatments, 
plates were normalized by dividing intensity with cell count. Figure 16 shows treatment 
No SM + UV to have the highest concentration of the p21 positive cells indicating the 
most cell damage. Treatment BSM + UV had a reduced the p21 concentration compared 
to No SM + UV. These results were similar to previous experimentation [57].  
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Figure 16: Experiment 1 p21 Intensity (n=8). 
JMP is a powerful statistical software that can fit multiple models against full-
factorial explanatory variables. ANOVA was done with all quantitative measurements 
available on ImageJ listed in Table 4.  These additional parameters were treated as 
independent response variables in the hopes of identifying new metrics that explain 
variability between treatments, Figure 17.  
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Figure 17: Image of JMP Fit Model User Interface. The section highlighted blue are 
all the response variables tested. The red box shows all the explanatory variables; 
SM*UV evaluates how the interaction between treatments effects results. 
The parameters that showed significant difference between treatments aside from 
cell count and intensity, were min/max values and nucleus circularity. A logarithmic 
scale shows the mean minimum and maximum intensities from AF 488 images, Figure 
18. Minimum values correspond to dark areas in an image where no cells are present. 
Maximum values correspond to the highest areas p21 aggregated within a cell. This 
metric could serve as a gateway check to filter results that are abnormal. Based 
Experiment 1 results, minimum value should be less than 1 and maximum value should 
be 255.  
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Figure 18: Experiment 1 Mean Minimum and Maximum Intensities. 
Nucleus circularity is an additional parameter that seemed to be affected by 
treatment, Figure 19. Circularity output ranges from 0 (elongated shape) to 1 (perfect 
circle). Prior to UV irradiation, the nuclei circularity median was 0.64. Post UV 
irradiation, BSM treated nuclei had a circularity of 0.61 and No SM nuclei had a 
circularity of 0.57. This suggests UV irradiation negatively affects the circularity of 
nuclei and that the addition of BSM may help against that deformity.  
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Figure 19: Experiment 1 Circularity. 
4.1.3 Discussion 
From the results of Experiment 1, previous lab’s results were replicated and new 
parameters of interest were identified. Intensity values had to be normalized using cell 
count because variation in number of cells effected the overall intensity of each image. 
This variation in cell count was attributed to plate variation as well as BSM increasing 
the size of the cells. Qualitatively, cells looked appropriate and quantitatively, there was 
reduction of p21 damage when BSM was introduced.  
Two, new parameters were found to be affected by treatment: min/max intensity 
values and nucleus circularity. Min and max ranges were estimated to serve as a filtering 
step for image abnormality. Additionally, nucleus circularity was negatively affected by 
UV irradiation. This correlation may also capture cell damage similar to p21 presence. 
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These parameters were reevaluated with a higher sample number to conclude differences 
with statistical power in Section 4.6.  
4.2 FSM Treatment 
4.2.1 Objectives/Methods 
Sphingomyelin mechanism was not understood because BSM is unable to 
visualized within the cell.  Fluorescent sphingomyelin (FSM) was proposed to be an 
analog to BSM with the additional ability to be visualized under confocal microscopy. 
The objective for Experiment 2 was to find equivalence between FSM and BSM by 
replicating previous FSM procedure with a new secondary and comparing their 
intensities. FSM and current p21 secondary shared a common emission spectrum. A new 
secondary was needed to separately analyze FSM and p21 intensity, illustration shown in 
Figure 8. 
Goal 1: Replicate FSM procedure 
FSM was introduced as an equivalent to BSM to better understand 
sphingomyelin’s interactions within the cell. FSM’s concentration was previously 
optimized, however, imaging was needed to confirm its equivalence.  
Goal 2: Introduce new secondary AF 594 
A new secondary was needed to visualize both the FSM and p21 antibody. Goat, 
anti-rabbit IgG AF 594 was a new secondary, and one treatment group was stained using 
Secondary AF 594 in order to provide comparison to Experiment 1. The procedure 
between the different secondaries were not changed. This experiment highlighted 
differences in p21 positive fluorescence between the secondaries. 
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The factors to evaluate were sphingomyelin, UV irradiation, and secondary 
antibody. Treatments were separated by plate and they were the following: A - No SM + 
No UV + Secondary AF 594, B - No SM + UV + Secondary AF 594, C - No SM + No 
UV + Secondary AF 488, D - No SM + UV + Secondary AF 488, E - FSM + No UV + 
Secondary AF 594, F - FSM + UV + Secondary AF 594, G - BSM + No UV + Secondary 
AF 594, H - BSM + UV + Secondary AF 594, shown in Figure 20. If BSM and FSM 
were equivalent, treatments E, F, G, and H were hypothesized to the same. Additionally, 
if secondaries were equivalent, treatment A/C and B/D would share similar trends.  
 
Figure 20: Design of Experiment 2. There was total of 8 plates and 8 treatments with 
each plate receiving a different treatment. 
4.2.2 Results 
There were differences between intensities for the new substrates. Laser power 
had to be reduced from 18% to 5% to prevent oversaturation of the FSM and initially, the 
new secondary did not appear to be present in the well using previous settings from 
Secondary AF 488. Secondary AF 594 was not seen until the high voltage (HV) was 
increased from 700 to 900. The optimal settings for this experiment can be summarized 
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in Table 3. After settings were determined, all three channels displayed distinct stains; 
Figure 21A shows nuclei in the DAPI channel, Figure 21B shows FSM in the AF 488 
channel, and Figure 21C shows p21 presence in the AF 594 channel.  
 
Figure 21: Experiment 2 Confocal Imaging. A. DAPI channel displays cell nuclei. B. 
AF 488 Channel displays FSM. C. AF 594 Channel displays p21. 
After imaging was performed, images were processed, nested, and intensities 
were normalized by dividing by cell count. Figure 22 displays the different color p21 
intensities as well as Experiment 1 results. In Figure 22A, there were no intensity 
differences between the Secondary AF 488 for Experiment 1 and Experiment 2 indicating 
experimental results were similar using the old secondary. This indicates that procedure 
was repeated sufficiently.  
For Secondary AF 594, the expected results were no intensity differences between 
BSM and FSM. However in Figure 22B, Secondary AF 594 showed FSM treatment was 
not equivalent to BSM after UV irradiation. After UV irradiation, FSM treatment was 
equivalent in p21 postitive intensity as the No SM case with both having an intensity of 1 
compared to BSM having an intensity of 0.6.  
A B C 
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Figure 22: Experiment 2 p21 Intensity. A. Experiment 1 and Experiment 2 Secondary 
AF 488 intensities. B. Secondary AF 594 intensities. 
4.2.3 Discussion 
These results do not support the hypothesis that FSM and BSM carry the same 
protective effects. However, this may be due to the large differences in laser settings 
between channels. High voltage has an exponential relationship with the amount of 
energy introduced. There was a possiblity of involuntary excitation of the fluoro attached 
to FSM because the high voltage was so large in the AF 594 channel. This would cause 
the intensity of the p21 to increase to similar that of the No SM treatment.  
Laser settings should be more closely related to the settings used for Secondary AF 
488. This supports the need to optimize the secondary concentration. Additionally, once 
the concentrations are optimized, experimentation was needed to determine the 
appropriate incubation time so that FSM and BSM share the same protective properties. 
A 
B 
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The next series of experiments tried to address those issues. Experiment 3, Section 4.3, 
optimized Secondary AF 594 concentration and Experiment 4, Section 4.4, optimized 
sphingomyelin factor incubation time.  
4.3 Optimizing New Secondary Concentration 
4.3.1 Objectives/Methods 
In the previous experiment above, Section 4.2, it was concluded that Secondary 
AF 594 concentration needed to be optimized. The main purpose for this experiment is to 
find the Secondary AF 594 concentration needed to visualize p21 presence and to 
evaluate if a reduction of Hoechst concentration prevents oversaturation. Ideally, the 
same laser settings as Secondary AF 488 should be used.  
Goal 1: Optimize for new Secondary AF 594 
Secondary AF 488 concentration does not translate sufficiently when Secondary 
AF 594 is used. A new concentration is needed to better capture Secondary AF 594 with 
similar laser settings to that of Secondary AF 488. 
Goal 2: Evaluate reduction of Hoechst concentration 
Current DAPI channel laser settings remain at a low power, but nuclei tend be 
oversaturated with minor adjustment. The Hoechst concentration should be reduced from 
0.03% to 0.015% in order to decrease the likelihood of oversaturation. Confirmation is 
needed that these results will be sufficient to detect nuclei.   
Protocol was replicated with all concentrations the same except for the Secondary 
AF 594 and Hoechst. No sphingomyelin treatment was added to produce the highest p21 
positive concentration after UV irradiation. All plates received the reduced Hoechst 
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concentration of 0.015%, and the four different secondary concentrations evaluated were: 
1:100, 1:200, 1:300, and 1:400, summarized in Figure 23. The expected result was to find 
a concentration with high intensity after UV irradiation and low variability within the 
plate. 
 
Figure 23: Design of Experiment 3. There were 8 plates and 8 treatments with each 
plate receiving a different treatment. 
4.3.2 Results 
Experiment 3 tried to find the concentration resulting in low variation between 
wells and better contrast of p21 positive intensity with less laser power. Laser settings for 
AF 594 channel were adjusted to share similar settings to Secondary AF 488 specified in 
Table 3. In Figure 24A, nuclei were clearly present in the DAPI channel. Qualitatively it 
was confirmed that reduction of Hoechst concentration did not affect visualization of 
nuclei and reduced the risk for oversaturation. In Figure 24B, AF 594 was able to detect 
red pockets of intensity which corresponded to p21 positive cells for all concentrations. 
Further analysis was needed to quantitatively find the highest concentration with the 
lowest variability. Three images were taken in the center of each well.  
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Figure 24: Experiment 3 Confocal Imaging. All images displayed derived from plates 
exposed to UV irradiation. Each column represents a different secondary concentration. 
A. DAPI channel display cell nuclei. B. AF 594 channel displaying p21 presence within 
cell. 
Images were processed, averaged per plate, and normalized by p21 intensity by 
cell count, Figure 25. After UV irradiation, the three concentrations, 1:200, 1:300, 1:400, 
were not significantly different having intensity range of 0.046 to 0.062. The 
concentration 1:100 had the highest intensity per cell, indicating the highest p21 damage. 
However, it also had the largest variation meaning that there were other confounding 
factors that could be responsible for its high intensity.  
A 
B 
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Figure 25: Experiment 3 Intensity. Average intensity was plotted per treatment along 
with their standard deviations. 
4.3.3 Discussion 
While having a too low concentration can prevent visualization of marker, a too 
high concentration could have adverse effects as well. A too high concentration can flood 
the area with markers that negate blocking solution and lead to non-specific binding. 
Additionally, high concentration lead to high costs. Finding the balance between intensity 
and variability is an appropriate method for determining optimal concentration. 
Therefore, concentration 1:100 was determined as too high of a concentration.  
Ultimately, a concentration of 1:200 qualitatively showed the best results. It was 
also determined that secondary AF 488 still showed a better contrast. Therefore, 
Secondary AF 594 with a concentration of 1:200 should only be used to determine BSM-
FSM equivalence for sphingomyelin location effort; Secondary AF 488 should be used 
for all other BSM-NoSM comparison.  
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4.4 Optimizing Incubation Time 
4.4.1 Objectives/Methods 
In a previous experiment above, Section 4.2, it was concluded FSM and BSM did 
not share the same photoprotective properties when using a 24 hour incubation period. 
There is an added aspect of external variability as incubation time increase. This 
experiment’s focus to is determine a reduced incubation time that would show FSM and 
BSM equivalence. 
Goal 1: Optimize FSM incubation with new Secondary AF 594 concentration 
After finding the optimal concentration of Secondary AF 594, incubation time of 
FSM and BSM was reevaluated. The best incubation time would be where intensities of 
BSM and FSM are similar with low variation within plates. Additionally, results should 
replicate the trend of Experiment 1 in which UV treated plates have similar intensities to 
No UV case indicating introduction of BSM/FSM helps reduce cell damage. 
The factors for this experiment included sphingomyelin (FSM or BSM), UV 
irradiation, and incubation time of sphingomyelin. A full factorial resulted in 16 different 
treatments, Figure 26. Each plate contained half wells with BSM and the other half with 
FSM. This ensured that plate to plate variation did not contribute to the variation 
observed in BSM and FSM. Previously, incubation was done at 24 hours and this 
incubation time should ideally be reduced to decrease variability among plates. Four 
incubation times were evaluated: 1 hour, 2 hours, 12 hours, and 24 hours. In order to limit 
the amount of additional variation, all steps except the FSM and BSM introduction 
should be performed approximately the same time. Therefore, plates first reached 70% 
confluency then incubation of BSM and FSM was done from longest to shortest (ie.24 
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hours, then 12 hours, etc.). At each treatment time, all plates were taken out of incubator 
to ensure that all plates had the same growing conditions.  
 
Figure 26: Design of Experiment 4. There were 8 plates and 16 treatments with each 
plate receiving two different treatments. 
4.4.2 Results 
Experiment 4 tried to find the most appropriate time BSM and FSM media should 
be exposed to keratinocytes to produce protective effects. It aimed to understand the time 
needed for proper intake of the sphingomyelin as well as if prolonged exposure could 
cause negative effects.  
The process of UV irradiation and fixing remained the same, however, 
immunostaining was updated to optimize fluorescence parameters from Experiment 3 
(i.e. Secondary AF 594, 1:200 and Hoechst, 0.015%), Section 4.3. Qualitatively, 
differences in intensities were comparable among the different treatments, Figure 27. 
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Figure 27: Confocal imaging of AF 594 channel. 
Plates were then imaged, processed, and averaged. The intensity was divided by 
cell count to normalize results. Initial results showed that there were no significant 
differences between the No UV plates and differences among the incubation times after 
UV; Figure 28 shows No UV treatment to share an intensity range of around 0.10 to 0.13 
(i.e. an interval of no greater than 0.3).  
Because there were no differences in the No UV case, determination of optimal 
incubation time was then pivoted to only UV treatments. FSM and BSM intensities were 
similar when isolated by incubation time expect for the 1-hour timepoint. At 1 hour, BSM 
had an intensity of 0.264 compared to FSM with 0.127. This indicated that BSM is 
slower to uptake than FSM and it may be due to small differences in molecular structure. 
At 2 hours, intensities between FSM and BSM were not significantly different and 
standard deviations were low. At 12 hours, there is was an increase in intensity for both 
sphingomyelin treatments. It is unclear what caused this rise, but it may be due to 
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decrease in activation of sphingolipid ceramide pathway at that specific time point.  
Lastly at 24 hours, shared similar results to 2 hours, however, that increased experimental 
time can add externally variability to the results.  
 
Figure 28: Experiment 4 Intensity. Mean intensities were plotted as well as their 
standard deviation. 
4.4.3 Discussion 
Experiment 4 tried to find the optimal incubation time required for BSM and FSM 
equivalence with the most photoprotective effects. If sphingomyelin did protect the cells, 
their intensities should be equivalent to the No UV case. Results showed that incubation 
for 2 and 24 hours had the lowest increase in intensity as well as BSM and FSM shared 
similar results. Final determination of incubation was based on reducing experimental 
variation. The longer sphingomyelin is incubated the increase of variation due to 
environmental factors, such as incubation conditions and cell growth. Because both time 
points had equivalent intensities, the 2-hour incubation should be used to limit variation 
and overall decrease experimental time and resources.  
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4.5 FSM Localization 
4.5.1 Objectives/Methods 
In the previous experiment above, Section 4.4, a 2-hour time point was concluded 
to be the optimal time for FSM and BSM incubation. The main purpose of this 
experiment was to confirm FSM and BSM equivalence and to investigate the location of 
FSM. Additionally, Secondary AF 488 was used for some BSM and No SM treatments to 
compare results to previous experiments.  
Goal 1: Compare FSM and BSM 
Further experimentation comparing BSM and FSM is needed using the improved 
protocol from Experiment 3 and Experiment 4, Section 4.3 and 4.4 respectively. These 
changes include a 2-hour sphingomyelin treatment time, increased concentration of 
Secondary AF 594, and reduced concentration of Hoechst to 0.015% to optimize for 
imaging parameters. 
Goal 2: Observe the distribution of FSM within keratinocytes  
Sphingomyelin mechanism is still unknown. Figuring out its location before and 
after UV irradiation can help understand its mechanism of protection against cell damage. 
FSM allows visualization under confocal imaging. If FSM and BSM are comparable, 
localization efforts of FSM can allow hypothesis of mechanism of sphingomyelin.  
Because Secondary AF 488 showed a better contrast compared to Secondary AF 
594, half of the plates were stained with Secondary AF 594 for BSM and FSM 
comparison and the other half were stained Secondary AF 488 to confirm appropriate 
staining technique compared to previous experiments. Figure 29 shows the 8 different 
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treatment evaluated: A – No SM + No UV + Secondary AF 488, B – No SM + UV + 
Secondary AF 488, C – FSM + No UV + Secondary AF 594, D – FSM + UV + 
Secondary AF 594, E – BSM + No UV + Secondary AF 488, F – BSM + UV + 
Secondary AF 488, G – BSM + No UV + Secondary AF 594, and H – BSM + UV + 
Secondary AF 594. If hypotheses were assumed correct, treatments C/G and D/H should 
be equivalent, treatments E/G and F/H should share the same trend, and treatments 
A/B/E/F should be equivalent to previous experimentation.  
 
Figure 29: Design of Experiment 5. There were 8 plates and 8 treatments with 4 plates 
receiving Secondary AF 488 and the other receiving Secondary AF 594. 
4.5.2 Results 
Plates were imaged, processed, and averaged before data analysis. Because 
intensity range between secondaries were different, plates were separated by secondary 
type. Intensities were normalized by dividing cell count. 
There was insufficient evidence to conclude a difference between BSM and FSM 
using Secondary AF 594, Figure 30. Their means are slightly different between 
treatments, but their standard deviations overlap each other giving the possibility that 
their true means may be the same. Furthermore, there was no significant difference 
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between UV and No UV treatment. This indicates FSM and BSM are comparable as well 
as they may have protected plates from p21 damage during UV irradiation. There was no 
control case (i.e. No SM) that was stained with Secondary AF 594, however, the No SM 
+ UV treatment was observed to exceed the intensities in the BSM and FSM case.  
 
Figure 30: Experiment 5 AF 594 Intensity. Average intensity values were plotted as 
well as their standard deviations. 
When we observed the plates stained with Secondary AF 488, we expected to see 
a large increase in intensity for No SM + UV case. However when examining intensities 
using Secondary AF 488, there was not a significant difference between all treatments, 
Figure 31. Similar to Secondary AF 594, their standard deviations overlapped each other. 
This means it cannot be concluded whether their true means were different or the same. 
Although direct true mean differences cannot be compared, their sample means did show 
an increase of 0.065 for the No SM case and a decrease of 0.005 using BSM after UV 
irradiation. This supports the hypothesis that BSM provides protective benefits against 
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UV irradiation. In order to gain statistical power for this hypothesis, more samples were 
needed to better estimate the true mean treatment population and variation of the data 
must be reduced.  
 
Figure 31: Experiment 5 AF 488 Intensity. Average intensity values were plotted as 
well as their standard deviations. 
Qualitative analysis using the FSM channel attempted to visualize sphingomyelin 
within the cell. The confocal microscope enabled with a 100x objective was used to 
capture images of cells with higher magnification allowing for greater specificity. Images 
were made binary, an ellipse was formed around one cell, a Gaussian Blur filter was 
applied (Section 3.7.4), and a surface plot was created, shown in Figure 32. A surface 
plot takes the intensity of each pixel and plots it in a 3-dimensional matrix. The DAPI 
channel was compared to determine the location of the cell’s nucleus, and FSM did not 
appear to be located within the nucleus. The surface plot showed FSM intensity to be 
high around the nucleus’ perimeter and gradually diminish as analysis traveled radially 
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outward. There appeared to be a low concentration of fluorescence at the cell’s outer lipid 
membrane.  
 
Figure 32: Surface Plot of FSM Location within Cell. A. Cell image at 100x 
magnification. An ellipse, shown as yellow, surrounds the cell of interest and Gaussian 
Blur filtered the inside of the ellipse. B. Surface plot of the ellipse with peaks being areas 
of high fluorescence. 
Because a cell is somewhat radially symmetrical, a slice starting from the center 
of the nucleus extending across its cytoplasm to the outer lipid membrane allowed a 2-
dimensional trace of intensity. A new rectangular area of interest was created, Gaussian 
blur was applied, and a profile plot was created. A profile plot analyzes that pixel’s 
intensity versus its distance relative to how far it is from the leftmost rectangular line. 
Multiple cells were analyzed; Figure 33A is the 2nd image taken from a well with 
treatment FSM + UV and Figure 33B is the 3rd image taken from the same well. Cell 
variation such as size, circularity, count, etc limited the grey values range from matching 
exactly from cell to cell; this did not allow for direct grey value comparison. The same 
observations were seen in profile as with the surface plot with highest FSM concentration 
closest to the nucleus and low concentration at the cell’s lipid membrane.  
A B 
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Figure 33: Profile Plot of FSM Location within Cell at 100x. A and B are different 
cells of interest on different images. Yellow boxes for the profile plots are drawn starting 
from their nucleus to their outer lipid membrane. Their corresponding profile plots are on 
their right. 
4.5.3 Discussion 
This experiment tried to confirm FSM and BSM equivalence and confirm results 
seen in previous experimentation. Although large standard deviations caused insufficient 
statistical significance, observationally the p21 intensities were equivalent among BSM 
and FSM cases stained with Secondary AF 594. Additionally, BSM and No SM cases 
stained with Secondary AF 488 showed similarities with previous experimentation with 
the No SM + UV treatment having a higher intensity then the BSM + UV treatment.  
A 
B 
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When observing at 100x magnification, there was high cell variation within 
images as well as between images. However, there was a trend in FSM intensity seen in 
the surface plot. FSM had the greatest concentration in the area surrounding the nucleus. 
Because sphingomyelin is hydrophobic, FSM is most likely localized in vacuoles this is 
seen as globular pockets of fluorescence along the nucleus. 
The following is a proposed mechanism of sphingomyelin. Sphingomyelin enters 
cell membranes and disrupt well-formed lipid rafts. This disruption causes a significant 
decrease in UV-induced reactive oxygen species (ROS) synthesis. Additionally, 
sphingomyelin breaks down into ceramide and caused ceramide-dependent activation of 
PKCζ [70]. This provides the benefit of reduction in p21 upregulation, reduction of 
apoptotic markers such as DNA fragmentation, and causes an increase in epidermal 
proliferation upon UV irradiation [71]. 
4.6 Experiment Replication with Updated Protocol 
4.6.1 Objectives/Methods 
The purpose this experiment was to reach statistical significance with the trends 
observed in Experiment 1 or at the very least record some of the unexplained variation. 
The protocol found in Appendix A was modified to enhance these trends while reducing 
intra-subject standard deviation, Experiments 2 - 5. 
Goal 1: Replicate previous experimentation results using new substrates, materials, and 
slightly modified procedure. 
Significance between BSM and No SM was not concluded in Section 4.5 because 
of the limited sample size. In Experiment 5, the protocol was updated to optimize for 
61 
 
equivalence of BSM and FSM effects. Therefore, replication of the Section 4.1, with the 
updated protocol, was needed to understand the variation between results. If results were 
equivalent to Experiment 1, we expected to see a large intensity increase in No SM + UV 
treatment and low, equivalent intensities for all other treatments.  
Goal 2: Understand variation between experiments 
In order to confirm results similar to Experiment 1, low variation must be 
observed within plates and cell counts should be consistent with previous experiments. 
Additionally, we want to understand the variation between experiments. In this 
experiment, some immunostaining substrates came from a different batch. This can cause 
additional variation between experiments and ultimately affect results. 
The main differences in protocol were a 2 hour sphingomyelin incubation time 
and reduction of Hoechst concentration to 0.015%. Because Secondary AF 448 yields a 
higher contrast between non and p21 positive cells, only Secondary AF 488 was used. 
Eight plates with keratinocytes were grown until at least 70% confluency. Then, 
Experiment 1 treatment groups were repeated (A – No SM + No UV, B – BSM + No UV, 
C – No SM + UV, and D – BSM + UV) using the updated protocol, seen in Figure 34.  
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Figure 34: Design of Experiment 6. There were a total of 8 plates and 4 treatments with 
2 plates receiving each treatment. 
4.6.2 Results 
This experiment attempts to understand the intra-subject variability of 
experiments. Differences were first observed during confocal imaging with one treatment 
case significantly differing in cell count compared to other treatment cases. Qualitatively, 
it was noted the BSM + UV plates had uncharacteristically less cells in its wells, Figure 
35C. Furthermore, BSM + UV images may have had some nonspecific binding seen in 
Figure 35C where there was p21 fluorescence but no nuclei present in the DAPI channel 
corresponding to those areas.  
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Figure 35: Experiment 6 Confocal Imaging. Using a 20x objective, a larger portion of 
well was observed. The DAPI channel in blue displays cell’s nuclei and the AF 488 in 
green displays p21 within cell. A. Image of well treated with No SM and UV irradiation. 
B. Image of well treated with No SM and No UV. C. Image of well treated with BSM 
and UV irradiation. There appears to be less nuclei compared with the other images. D. 
Image of well treated with BSM and No UV. 
Images were then processed and averaged for data analysis. Figure 36 
quantitatively shows that treatment BSM + UV had the lowest cell count with an average 
of 22 cells per image. While it is true, UV irradiation kills some cells, it not typical that 
BSM, pre versus post UV had a percent change of around 70%. This and the fact that the 
variability of cell counts was high among the plates, raised concerns of significance with 
results of p21 intensity.  
 
A
a
C 
B 
D 
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Figure 36: Experiment 6 Cell Count. Average cell count was plotted as well as their 
standard deviations. 
P21 intensities were again normalized by dividing by cell count. Results showed 
that BSM increases p21 concentration compared to No SM + UV. This result is 
contradictory with Experiment 1, Figure 37.  
 
Figure 37: Experiment 6 AF 488 with for Experiment 1 for Comparison. 
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4.6.3 Discussion 
The purpose of this experiment was to replicate Experiment 1 using an updated 
protocol. Due to concern of abnormal cell count and p21 fluorescence in the BSM + UV 
treatments, results were likely inaccurate. In the BSM + UV plates, cell count dropped 
about 70% and qualitatively images had some non-specific binding, shown in Figure 
35C. The main source of error may be due to old cells with abnormal morphology. The 
keratinocytes that were seeded in these plates came from passage number 5 with 
prolonged time in the freezer. This can cause abnormal cell growth and may have 
contributed to their sensitivity when exposed with UV. This further highlighted the high 
intra-subject variation experienced between experiments.  
4.7 Compiled Data Analysis 
4.7.1 Objectives/Methods 
 One last meta-analysis was performed to understand variation between 
experiments and to evaluate experimental parameters found in Experiment 1. Experiment 
1- 6 results were combined to gain a larger sample size and no new experiments were 
performed due to limited access to the lab because of COVID-19.  
Goal 1: Understand inter and intra subject variation 
Previous experimentation found that there was a difference between treatments, 
but their unexplained variation was large enough to negate significance. Further 
combination of experiments could yield a quantitative value for intra subject variation.  
Goal 2: Evaluate treatment effects on experimental parameters and its significance  
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New experimental parameters were found in Experiment 1 to further analyze the 
difference between treatments. Because a large experimental study was not performed, 
combining experiments can understand correlations and significance of new parameters. 
Goal 3: Estimate number of trials needed for statistical significance 
By understanding the variation between experiments, the number of experiments 
needed to conclude significance was estimated. Currently, any statistical analysis 
performed on an individual experiment is not sufficient because it lacks degrees of 
freedom (i.e. statistical power).  
4.7.2 Results 
Variability within plates was something that greatly affected the precision of the 
data. This is unideal because high variability requires more samples to estimate the true 
population value. Mean intensities normalized by cell count and their standard deviations 
were plotted for all plates separated by experiment, UV treatment, and SM treatment, 
Figure 38.  
The red rectangle in Figure 38 showed that plates stained with Secondary AF 594 
in Experiment 2, Section 4.2, displayed larger standard deviations compared to the other 
experiments. This may be due to the lack of contrast from a subprime secondary 
concentration; variation was reduced as the secondary concentration was optimized in 
Experiments 2 and 3. Because variability from secondary was eliminated in later 
experiments, results from Experiment 2 was disregarded from compiled data analysis, 
recorded in Table 6. Variance was later used to estimate sample size, Section 4.7.2.6.  
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Figure 38: Experiment 7 Intensity Standard Deviations. Secondary AF 488 and 
Secondary AF 594 were differentiated. Red rectangle highlights Experiment 2 as having 
plates with larger standard deviations compared to other experiments. 
Experiments 1- 6 were used for data analysis for a sample size of 56. However, 9 
plates were excluded from analysis due to high or unexplained variability, summarized in 
Table 6, for total of n=20 with Secondary AF 488 and n=27 with Secondary AF 594. 
Analysis using the DAPI channel were combined between secondaries (n=47), but 
intensity analysis using secondaries were separated due to differences in contrast between 
fluorescence.  
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Table 6: Excluded Plates prior to Compiled Data Analysis (n=9). 
Experiment Treatment Plates 
Excluded 
Reasoning 
2 
Section 4.2 
No SM, No UV, AF 
594 
No SM, UV, AF 594 
FSM, No UV, AF 594 
FSM, UV, AF 594 
BSM, No UV, AF 594 
BSM, UV, AF 594 
Unknown reason for high variability within 
plates, Figure 38. 
Secondary AF 594 needed to be optimized 
in order to image with appropriate laser 
settings and enough contrast. 
3 
Section 4.3 
1:100, UV Intensity was significantly different than the 
other concentrations. It also had a large 
standard deviation. 
6 
Section 4.6 
BSM, UV (2x) Abnormally low cell count due to harsh 
BSM application or some other unexplained 
variation.  
 
Along with the cell count and p21 intensity, additional experimental parameters 
were evaluated from Experiment 1, Section 4.1. An explanation of the new parameters is 
found in Table 4. Table 7 summarizes the parameters evaluated as well as the main 
results concluded from analysis.  
Table 7: Experiment 7 Summary of Results. 
Parameter Thesis Section Results 
Cell count Section Cell 
Count 4.7.2.1 
UV irradiation significantly lowers the cell count 
regardless of treatment. It is estimated the UV 
irradiation reduces cell count by 24%. 
P21 intensity  Section 4.7.2.2 After normalizing by dividing by cell count, there 
is insufficient evidence to support the hypothesis 
that BSM has protective effects after UV 
irradiation.  
Min and Max 
Grey Values 
Section 4.7.2.3 Min and max values help determine if image 
contrast is abnormal, however, the range for 
filtering was adjusted and relaxed to reflect 
experimental data.  
Circularity Section 4.7.2.4 UV irradiation significantly lowers circularity of 
nucleus regardless of treatment.  
Correlations Section 4.7.2.5 Circularity correlated with perimeter and average 
size.  
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Count correlates with Total Area.  
Sample Size 
Estimation 
Section 4.7.2.6 Because of large inter and intra variation, 
additional trials are needed to conclude 
significance with appropriate confidence.  
 
4.7.2.1 Cell Count  
Cell count was determined by counting the number of stained nuclei from the 
DAPI channel, Section 3.7.1. The cell count for each image was taken and the average 
cells per image was taken for each plate. With a sample size of n=47, there is sufficient 
evidence (t < 0.0001) to conclude a decrease in cell count after UV irradiation, Figure 39. 
Using the parameter estimates, it is estimated each well contains 78 cells per image and 
that UV irradiation removes 19 cells from each image. That reduction of 24% supports 
the need to normalize intensities by cell count and UV irradiation. Furthermore, 24% 
could serve as a metric to evaluate if UV irradiation was effectively administered. If cell 
count from pre to post UV irradiation differs substantially, it could be due to inadequate 
or too long UV exposure time.  
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Figure 39: Experiment 7 Cell Count. A. Average cell count separated by 
sphingomyelin and UV treatments. There was significant evidence * < 0.0001 that there 
was a difference between number of cell before and after UV irradiation. B. Parameter 
estimate is the prediction of how the response variable changes for a change in the 
explanatory variable. * t < 0.0001. 
4.7.2.2 P21 Intensity 
P21 intensities were separated depending on secondary because overall, 
Secondary AF 594 appeared dimmer than Secondary AF 488. For both analyses, there 
was insufficient evidence to reject the hypothesis that there are no differences observed 
between sphingomyelin and UV treatments, Figure 40. This lack of significance is due a 
combination of high variability seen by the large standard deviation bars and from the 
low levels of contrast between the No UV and UV intensities. The largest delta between 
No UV and UV case was 0.171 meaning measurement needs to be very accurate to 
capture the true mean difference.  
* 
* 
* 
A
B 
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Figure 40: Experiment 7 p21 Intensities. Secondary AF 448 are the green bars (n=20) 
and Secondary AF 594 are the red bars (n=27). 
4.7.2.3 Min and Max Grey Values 
Previous filtering minimum and maximum ranges were based on Experiment 1 
results (i.e. minimum value should be less than 1 and maximum value should be 255), 
Section 4.1. However, range should reflect larger data set values. After excluding non-
ideal results, summarized in Table 6, a new filtering range was established. Minimum 
values should continue to be less than 1 and maximum values can have a range from 250 
to 255, Figure 41. There appeared to be tendency for max values to reach 255. This max 
value means that the detector was saturated past the laser’s detection limit and was unable 
to record the true maximum intensity. Tracking minimum and maximum values range 
ensures that the contrast between images are not abnormal and further efforts should try 
to prevent oversaturation of intensities.  
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Figure 41: Experiment 7 Minimum and Maximum Values. 
4.7.2.4 Circularity 
Description of circularity can be found in Table 4. Previously, Experiment 1 
showed nuclei circularity was affected by UV irradiation. With the additional 
experiments, circularity is statistically different between no UV and UV irradiation, 
Figure 42. It is predicted that average nucleus circularity is 0.73 and decreases by 0.03 
when exposed to UV irradiation. Not only does UV kill cells, it can also cause 
morphological changes in the cell’s structure. Circularity of the cell’s outer lipid 
membrane was not analyzed because there was no clear visualization method, however, 
we can assume morphological changes in the nucleus translates to larger changes of the 
whole cell. Observationally it was seen that cells incubated with BSM appeared larger 
and less circular than those treated without. This could contribute to the cell count 
observed per plate.  
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Figure 42: Experiment 7 Nuclei Circularity. A. Boxplot of circularity of nuclei based 
on sphingomyelin treatment and UV irradiation. There is significant difference between 
No UV and UV results, *< 0.001. B. Parameter estimate is the prediction of how the 
response variable changes for a change in the explanatory variable. * t < 0.001. 
4.7.2.5 Correlations  
Correlation is a measure of how two quantitative variables relate to each other. 
Variables can be positively correlated if they both increase/decrease at the same time or 
negatively if they move in opposite directions [72]. Correlation is considered strong when 
their r value is larger than 0.7. The following 5 quantitative variables were evaluated for 
correlations: cell count, total area, average size, perimeter2, and circularity.  
Based on the equation for calculating circularity, Equation 3, the following 
relationships should hold true: circularity directly proportional to average size, circularity 
inversely proportional to perimeter2, and average size directly proportional to perimeter2.  
𝐶𝑖𝑟𝑐𝑢𝑙𝑎𝑟𝑖𝑡𝑦 =  ସగ∗஺௥௘௔
௉௘௥௜௠௘௧௘௥మ
  (Equation 3) [73]  
Note: Average size is equivalent to Area.  
* 
* 
* 
A
B
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The correlation matrix, shown in Figure 43, shows the following strong 
relationships: cell count α total area, average size α perimeter2, and perimeter2 α 
1/circularity. A strong correlation between circularity and average size was not observed.  
 
Figure 43: Correlation Matrix. The narrower the ellipse, the more related the variables. 
Note: These observations relate to the nuclei of each image, not the overall shape of the 
cell.  
4.7.2.6 Sample Size Estimation 
Plate standard deviations were previously plotted, and high deviations were 
removed from analysis, Figure 38. Variance is alternative metric similar to standard 
deviation; it calculates how varied a sample is and can be calculated manually using 
Equation 4. 
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𝑠ଶ =  ஊ(௑ି௑
ത)మ
ேିଵ
    (Equation 4) [74] 
Mean and variance of intensities were found to be different depending on 
secondary used, Figure 44. Secondary AF 488 had a mean of 0.352 with a variance of 
0.0127. Secondary AF 594 had a mean of 0.143 with a variance of 0.00754.  
 
Figure 44: Experiment 7 Mean and Variance of Intensities. A. Mean plate intensities 
differing by secondary. B. Mean variance of intensities differing by secondary. 
 
An unbiased population variance can be estimated using sample variance obtained 
from the data, Equation 5. 
𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑣𝑎𝑟𝑖𝑎𝑛𝑐𝑒 = ቀ ௡
௡ିଵ
ቁ ∗ 𝑠𝑎𝑚𝑝𝑙𝑒 𝑣𝑎𝑟𝑖𝑎𝑛𝑐𝑒  (Equation 5) [75] 
Additionally, population standard deviation was estimated using the calculated 
population variance, Equation 6. 
𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 =  √𝑣𝑎𝑟𝑖𝑎𝑛𝑐𝑒    (Equation 6) [75] 
Sample size estimation can be determined using Equation 7.  
A B
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𝑛 ≥  ቀ௖௥௜௧௜௖௔௟ ௩௔௟௨௘∗௦௧௔௡ௗ௔௥ௗ ௗ௘௩௜௔௧௜௢௡
௟௘௩௘௟ ௢௙ ௘௥௥௢௥
ቁ
ଶ
    (Equation 7) [74] 
Level of error refers to the specificity or accuracy of results. Generally, the level 
of error is less than 5% of the population parameter or 5% of mean value but can be 
adjusted based on application. Calculation was done using a max level of error of 5%, 
10%, and 15% of the mean. 
Table 8 summarizes sample sizes needed for various confidence levels and levels 
of error. With a specificity of 0.05 and a confidence level of 95%, there was no difference 
between treatments using Secondary AF 488. Additional testing is needed to decrease the 
level of error and increase the confidence level. Secondary AF 594 requires much larger 
sample sizes due its low intensity values.  
Table 8: Sample Size Estimation. 
Confidence 
Level 
Critical 
Value 
 
Secondary AF 488 Secondary AF 594  
Max Level of 
Error 
Sample 
Size 
Max Level of 
Error 
Sample 
Size 
90% 1.645 5% Mean 0.0176 117 0.0072 416 
10% Mean 0.0352 30 0.0143 104 
15% Mean 0.0528 13 0.0215 47 
95% 1.96 5% Mean 0.0176 166 0.0072 590 
10% Mean 0.0352 42 0.0143 148 
15% Mean 0.0528 19 0.0215 66 
99% 2.575 5% Mean 0.0176 286 0.0072 1018 
10% Mean 0.0352 72 0.0143 255 
15% Mean 0.0528 32 0.0215 114 
 
4.7.3 Discussion  
The purpose of this experiment was to understand sources of unexplained 
variation and to predict how they affected the results. Results from Experiments 1 – 6 
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were combined and after excluding abnormal plate values, cell nuclei and p21 intensities 
were analyzed.  
Data analysis revealed UV irradiation caused a difference in cell count of about 
24%. Images exposed to UV irradiation had approximately 24% less cells than those that 
did not. The results may be due to a series of factors such as cell growth, harsh treatment, 
exposure time. This metric could be used to confirm UV irradiation was effectively 
administered.  
Overall, p21 intensities were not statistically different between treatments. This 
was due to high variation between plates and further work is needed to mimimize this 
variation. It was observed that Secondary AF 594 had lower contrast than Secondary AF 
488. Therefore the use of Secondary AF 488 should be exclusively used because of the 
following reasons: location of FSM and BSM were documented in Experiment 5 and 
eliminated the need to use FSM, Secondary AF 488 had higher contast than Secondary 
AF 594, and Secondary AF 488 requires less concentration than Secondary AF 594 
which reduces regent cost and decreases non-specific binding.  
Using minimum and maximum intensity values as reference, intensity 
oversaturation may have contributed to the results. The number of times max values were 
255 showed sensitive laser settings were to oversaturation. Additionally, a minimum 
value range of 0-1 and a maximum value range from 250-255 was established to serve as 
a quality check for the normality of the images.  
Nucleus cicularity was seen to negeatively be impacted by UV irradiation. 
Because morphological changes of nucleus is expected to be applified in whole cell, UV 
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irradiation is expected to further affect cell’s shape. Using a correlation matrix, the 
following relationships were confirmed: cell count proportional to total area, nucleus size 
proportional to nucleus’ perimeter2, and perimeter2 inversely proportional to nucleus 
circularity.  
Lastly, population standard deviations were estimated using the sample variance to 
predict number of samples needed for different error and confidence levels, summarized 
in Table 8. Additional testing is needed to decrease the level of error and increase the 
confidence level. Secondary AF 594 required much larger sample sizes due its low 
intensity values. 
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5 CONCLUSION 
Overall, there were a total of 6 experiments and one meta-analysis. All 
experiments had goals that aligned with one of the three objectives: 1. Observe 
differences between cells exposed with sphingomyelin versus without 2. Visualize 
sphingomyelin within the cell and 3. Identify experimental parameters that contribute to 
variation in results. Further experimentation was halted due to COVID-19; however, 
additional experiments are outlined below and should be performed when lab resumes. 
Table 9 summarizes the goals and conclusions obtained from each experiment. 
In Experiment 1, the best indicator of cell damage was found to be p21 intensity 
normalized by cell count. P21 intensity peaked for the No SM + UV treatment and was 
lower for the BSM + UV treatment. This indicated similar results to previous 
experimentation that BSM provided some level of photoprotection against UV 
irradiation. Additional parameters were evaluated; min/max values were thought to help 
filter abnormal images, and nucleus circularity was found to be affected by treatments.  
In Experiment 2, FSM was introduced as an analog to BSM to visualize 
sphingomyelin within the cell. However, changes due to a new secondary, negatively 
affected the clarity of the results. Laser settings induced noise to the images and FSM did 
not show similar results to BSM. This highlighted the need to optimize the new 
secondary concentration and FSM/BSM incubation time. 
Experiment 3 and 4 tried to address the previous concerns. They resulted in an 
updated protocol that included the following: increased Secondary AF 594 concentration 
to 1:200, reduced Hoechst concentration to 0.015%, and reduced FSM/BSM incubation 
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time to 2 hours. All these changes were done to increase signal of p21 intensity and to 
decrease variation by reducing noise from the external factors.  
In Experiment 5, FSM was reevaluated for BSM equivalence. It was concluded 
BSM and FSM shared no significant differences. This means the location of the FSM and 
assumed location was consistent to BSM. After analysis of the FSM location, it is 
proposed that sphingomyelin disrupts well-formed lipid rafts that ultimately reduce p21 
upregulation (i.e., less cell damage). 
Experiment 6 and 7 attempted to find statistical significance between the 
treatment groups. Because there were high levels unexplained variation, sample size was 
too low to find statistical differences. Even though protocol was modified to produce the 
best images with the lowest variability, there were other sources of variation such as cell 
growth, equal UV treatment, and other handling differences. Using an estimate of 
population variance, sample sizes were estimated in Table 8 to conclude significance 
with varying confidence levels and error. 
Lastly in Experiment 7, the nucleus circularity, min/max values, and cell count 
were reevaluated to determine if a larger sample size observed the same trends. The min 
and max ranges were slightly modified relaxed, but appropriate quality image check. 
Additionally, the tendency for max values to be 255 showed how easily oversaturation 
could occur when adjusting laser settings. A cell count reduction of approximately 24% is 
an indication that the UV irradiation was effectively administered. Having too low of a 
cell count reduction could signal not enough irradiation and too high of a reduction could 
signal the opposite. Nucleus circularity was statistically different pre versus post UV 
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irradiation. This reduction in circularity may be indicative of lower cell health and could 
be an additional metric for evaluating cell damage.  
Table 9: Summary of Experiments and Results 
Experiment Goal Conclusions 
1. Replication of 
Previous 
Experimentation 
1: Replicate procedure and 
compare results. 
2: Identify new parameters that 
introduces variation between 
treatments. 
 
1: BSM reduced p21 positive intensity 
post UV irradiation. Results were similar 
to previous experimentation 
2: A variety of new parameters were 
evaluated. Nucleus circularity was 
affected by treatments. Additionally, min 
and max values should filter results that 
are abnormal.  
2. FSM 
Treatment 
1: Replicate FSM procedure 
2: Introduce new Secondary AF 
594 
 
1: FSM procedure did not yield the same 
protective effects as BSM.  
2: High laser settings for new Secondary 
AF 594 led to low contrast between 
treatments.  
 
There was a need to optimize for FSM 
incubation and new Secondary AF 594 
concentration. 
3. Optimizing 
New Secondary 
Concentration 
1: Optimize for new Secondary 
AF 594 
2: Evaluate reduction of Hoechst 
concentration 
 
1: A secondary concentration of 1:200 
had the best contrast with the least 
variability.  
2: Hoechst concentration of 0.015% 
reduced oversaturation of DAPI channel. 
4. Optimizing 
Incubation Time 
1: Optimize FSM incubation with 
new Secondary AF 594 
concentration 
 
1: An incubation time of 2 hours had the 
lowest p21 intensity, lowest variation 
within treatments, and had no differences 
between UV and no UV case.  
5. FSM 
Localization 
1: Compare FSM with BSM 
2: Observe the distribution of 
FSM within keratinocytes 
 
 
1: FSM and BSM were comparable as 
well as they may have protected plates 
from p21 damage. 
2: Profile plot shows globular pockets of 
fluorescence along the nucleus. After 
nucleus, intensity radially decreases until 
it reaches cell’s outer membrane. 
Sphingomyelin disrupts well-formed 
lipid rafts that ultimately reduces p21 
upregulation. 
6. Experiment 
replication with 
updated protocol 
1: Replicate previous 
experimentation results using new 
1: Results were contradictory with 
previous experimentation. This may be 
due to abnormality in cell count.  
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substrates, materials, and slightly 
modified procedure 
2: Understand variation between 
experiments 
2: There was high variation between 
experiments. 
7. Compiled data 1: Understand inter and intra 
subject variation 
2: Evaluate treatment effects on 
new parameters and its 
significance 
3: Estimate number of trials 
needed for statistical significance 
 
1: No statistical significance difference 
between BSM and No SM, but a slight 
trend was observed. Large standard 
deviation between plates as well as 
between experiments (ie. large intra and 
inter standard deviation). 
2: Min/max values and cell count could 
serve as quality check to ensure image is 
not abnormal. UV reduces cell count by 
approximately 24% and reduces 
circularity. Circularity correlates with 
perimeter2 and average size. Count 
correlates with Total Area. 
3: Table 8 summarizes the number of 
additional trials needed to reach 
statistical power using an estimation for 
variance of the population. 
 
This research was done in an attempt to introduce a novel method for UV 
protection. Unlike sunscreen, additional safety and efficacy data would not be needed 
because sphingomyelin is normally found in common foods and is already prevalent in 
the blood stream. Studies involving lab mice showed consumption of sphingomyelin 
could inhibit other types of cancer [55], Section 2.8.5. Obtaining quantitative evidence of 
its photoprotective properties and characterizing its metabolism within keratinocytes are 
the first steps in developing a drug to ultimately combat skin cancer.  
Ideally, to remove the variation observed between experiment, one large study 
should be conducted using many plates (n > 30). However, it poses too much of a strain 
on the lab’s resources. Not only would the lab have to procure large amounts of reagents, 
there would have to be many people to ensure plates received treatments at the same time 
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points. Additionally, even if resources such as reagents and personnel were obtained, the 
limiting factor would be the confocal microscope. It has been shown that the level of p21 
intensity decreases as the duration between staining and imaging increases. Currently, it 
takes approximately 30 minutes to image one plate. This makes the delta large between 
the first and last plate if more plates were being evaluated. 
Therefore, future lab experimentation should focus on further reducing intra-subject 
variation. Some procedural modifications could be starting experiments at consistent 
times in the day, monitoring ambient temperature, or implementing tests to check quality 
of reagents. Other modifications post processing could include filtering for min and max 
ranges, filtering for abnormal cell count, or using another marker for cell damage that has 
a higher sensitivity compared to p21. Currently, this thesis addresses the behavior of a 
monolayer of keratinocytes. Additional efforts of the lab include growing 3D constructs 
of keratinocytes to further characterize sphingomyelin’s effects in a more true, 
representative state. After effects are confirmed with statistical power, research efforts 
should focus on developing a method to introduce sphingomyelin to in-vivo models.  
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APPENDICES 
A. P21 Protocol 
 P21 Protocol 
 
Materials: 
Triton X, 1% goat serum, PBS, P21 primary (rabbit), formaldehyde, Hoechst stain, 
2ndary antibody (goat anti rabbit) 
 
Procedure: 
Day 1 
1. Remove media and wash once with PBS. All washes should be done gently. 
2. Fix cell with 3.7% formaldehyde and let sit for 15 minutes. 
3. Do three washes and add 0.1% triton X solution to each well. Let sit for 20 
minutes.  
4. Do 3 more washes and add 1% blocking solution to the cells. 
5. Let the blocking stay on overnight. It is ok to let blocking stay on for longer, 
though this is not true for the primary.  
6. Do three more washes with PBS. 
7. Add p21 primary antibody (1/400 dilution with PBS).  
8. Let p21 sit for about 9 hours. Letting the primary stay on for too long may 
negatively affect performance. 
9. Later the same day or the next day, remove P21 and wash three times with PBS. 
10. Add secondary (1/400 dilution) to each well. 
11. Let incubate (in darkness) for an hour. Wash three times with PBS. 
12.  Add 0.05% Hoechst stain to each well. Leave in darkness for 15 minutes. 
13. Wash three times and be sure to leave enough PBS to cover the each well. This 
allows for best imaging.  
14. Wrap in foil and image with confocal. 
 
Washing and Solution Preparation: 
Make sure to slowly drop PBS on the cells during washes. Rough treatment will damage 
cells and reduce confluency. 
Makes sure to slowly pull liquid out of the well in a corner. Going too fast or touching 
the bottom of the well will pull cells out. 
Pipetting small volumes should have the user slowly pull liquid in and out of the pipet (2-
3 times) to ensure accurate volumes. 
Always invert your stock and created solutions before using. This ensures that the active 
molecules reach the cells. 
 
Imaging: 
The images should allow for clear identification of p21 positive or negative cells.  
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B. ImageJ Macros 
P21 Intensity 
1. In ImageJ, click on Analyze > Set Measurements… 
 
2. In Set Measurements, select Area, Standard Deviation, Min & Max gray value, 
and Mean gray value. 
 
3. Open .oibs with separate channels and keep track the channel of interest (ie. the 
p21 channel).  
4. Open macro and run program. 
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setOption("ScaleConversions", true); 
run("8-bit"); 
run("8-bit"); 
run("Measure"); 
close(); 
Note: Functions can be repeated more than once and executed on the same macro. 
 
5. Results should appear in a results window and can be saved as a .csv.
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Cell Count 
1. In ImageJ, click on Analyze > Set Measurements… 
 
2. In Set Measurements, select Area, Standard Deviation, Shape descriptors, and 
Perimeter. 
 
3. Open .oibs with separate channels and keep track the channel of interest (ie. the 
DAPI channel).  
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4. Open macro and run program.
run("Subtract Background...", "rolling=90"); 
setOption("ScaleConversions", true); 
run("8-bit"); 
run("8-bit"); 
run("Convert to Mask"); 
run("Analyze Particles...", "size=90-Infinity pixel show=Outlines display exclude clear summarize"); 
run("Measure"); 
close(); 
Note: Functions can be repeated more than once and executed on the same macro. 
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5. Results should appear in a results window and can be saved as a .csv. 
 
 
 
 
